Radiation to the main tumor for stage IV lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether giving radiation to the main lung tumor, along with standard therapy (like chemo or immunotherapy), helps people with newly diagnosed stage IV lung cancer live longer. It is for people whose cancer does not have certain gene changes (EGFR, ALK, ROS1) and who have tumors in only a few other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed stage IV non-small cell lung cancer (NSCLC) that has spread to other parts of the body.
- Your cancer does not have changes (mutations) in the EGFR, ALK, or ROS1 genes.
- The main tumor in your lung is suitable for radiation and you don't need urgent chest radiation for symptom relief.
- You have tumors in 3 or fewer organ systems (like liver, bone, brain).
- You are healthy enough to receive standard cancer therapy (like chemotherapy or immunotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests whether a specific kind of radiation can be safely given to people with newly diagnosed metastatic lung cancer when cure isn’t possible. It’s meant to see how well the treatment can be delivered and how it affects outcomes in a specific genetic group of tumors.
This trial tests whether aiming radiation at the main lung tumor can help people with advanced lung cancer that has spread to many places. It is for people who have not had much treatment yet or whose cancer is currently stable.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
This trial compares continuing drug therapy alone versus adding local treatments (surgery or radiation) for people with stage IV lung cancer that has responded to initial treatment but still has a few remaining spots (oligometastatic). The goal is to see if targeting those spots with local therapy helps control the cancer longer.
This trial is testing whether giving radiation therapy after surgery can help prevent lung cancer from coming back in people who have already had chemotherapy and immunotherapy before surgery. It is for patients whose cancer had spread to chest lymph nodes and who still have some cancer left in those nodes after surgery.
Hear when a new Carcinoma, Non-Small-Cell Lung (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.